Comparison of General Anaesthesia and Sedation on the Stone Fragmentation in Lithotripsy

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT01361516
Collaborator
(none)
180
1
1
14.1
12.8

Study Details

Study Description

Brief Summary

The aim of the study is to compare the impact intravenous sedation versus general anesthesia on the efficacy of stone fragmentation in extracorporeal shock wave lithotripsy treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Anaesthesia and Lithotripsy
N/A

Detailed Description

The newer lithotriptors were reported to be less efficacious than the Dornier HM3 lithotriptor; and it is not clear the reason why there is decrease in efficacy of the new lithotriptors. Is it due to their small focal point or to increased patient movement while under intravenous sedation.When the patients get sedated then it will be difficult to control their respiratory movements. Retrospective comparisons suggest that intravenous may facilitate earlier discharge if no manipulation of the airway was done; but they are often associated with pain, hypoxemic respiratory episodes and disruptive movements during lithotripsy Instead of intravenous sedation, general anesthesia offer pain free procedures, no movement of the patient and controlled movement of the respiration leads to stable position of the urinary stones and receives persistent shock wave energy on to the stone bringing about better and early fragmentation. Hence we work on the hypothesis that the new generation shock wave lithotripters have a small focal point, every movement of the stone during the respiration or patient movement, will take the stone out of the focus and there results in loss of shocks leading to lithotripsy failure and use of more fluoroscopy for refocusing the stone.

Thus we think the proper choice of anesthetic technique will improve the efficacy of stone fragmentation in shock wave lithotripsy treatment at least in those who are obese and suffers from occult sleep- apnoea syndrome

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of General Anaesthesia and Sedation on the Stone Fragmentation Efficacy of the Third Generation Lithotriptor
Study Start Date :
Jul 1, 2011
Anticipated Primary Completion Date :
Jul 1, 2012
Anticipated Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intravenous sedation, General anaesthesia

IV sedation-ESWL under spontaneous respiration GA - ESWL under controlled respiration

Other: Anaesthesia and Lithotripsy
The efficacy of stone fragmentation during lithotripsy procedure is compared under two types of anaesthesia

Outcome Measures

Primary Outcome Measures

  1. Measurement of stone fragmentation during lithotripsy treatment under general anesthesia and sedation [One year]

    Stone fragmentation is measured as disappearence of the stone on flouroscopic monitoring and number of shocks utilised to break the stone during the lithotripsy treatment under general anesthesia (controlled ventilation) or with intravenous sedation(spontaneous ventilation)will be compared in this study.

Secondary Outcome Measures

  1. Anesthesia complications [One year]

    We are going to measure pain score (VAS 0-10)and postoperative hypoxemia, saturation below 90% well be considered as hypoxemic event

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Renal or upper ureteral stone of less than 2cm

  2. A.S.A Grade 1.2.3

  3. Age above 18 years

Exclusion Criteria:
  1. Mid or lower ureteral stones

  2. Bilateral renal stones

  3. Multiple stones

  4. Use of regional anesthesia

  5. Coagulopathies (thrombocytopenia, anticoagulation drugs)

  6. Suspected or documented difficult intubation

  7. History of chronic opioid abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hadassah Medical Organization Jerusalem Israel 91120

Sponsors and Collaborators

  • Hadassah Medical Organization

Investigators

  • Principal Investigator: Fayez Saifi, MD, Hadassah Medical Organization

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01361516
Other Study ID Numbers:
  • 021711-HMO-CTIL
First Posted:
May 26, 2011
Last Update Posted:
May 26, 2011
Last Verified:
Apr 1, 2011

Study Results

No Results Posted as of May 26, 2011